Global Point of Care Molecular Diagnostics Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Point of Care Molecular Diagnostics Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), Technology (RT-PCR, INAAt, and Other Technologies), End User (Hospitals, Homecare, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Point of Care Molecular Diagnostics Market was valued at USD 2,345.7 million in 2023 and is expected to reach USD 5,563.7 million by 2031 while growing at a CAGR of 11.4% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global point of care molecular diagnostics market growth. Point-of-care molecular diagnostics (POC-MD) involve a subset of molecular diagnostic tests conducted in various clinical settings, including hospitals, clinics, and physician offices, as well as non-traditional locations such as field hospitals, ambulances, or remote healthcare facilities. These tests are performed at or near the patient's location, offering swift results without requiring samples to be sent to a central laboratory.
Rising cases of infectious diseases like HIV, hepatitis, and respiratory infections, along with growing healthcare spending, propel the demand for point-of-care molecular diagnostics. Yet, cost limitations and challenges in quality control and standardization could hinder market expansion.
Furthermore, the global point of care molecular diagnostics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Technology Analysis
The Global Point of Care Molecular Diagnostics Market is segmented among RT-PCR, INAAt, and Other Technologies, based on technology. In 2023, RT-PCR accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By End User Analysis
The Global Point of Care Molecular Diagnostics Market is segmented among Hospitals, Homecare, and Other End Users, based on End User. In 2023, Hospitals accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Point of Care Molecular Diagnostics Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Abbott Laboratories, Siemens Healthineers, F. Hoffmann-La Roche Ltd, Becton, Dickinson and Company, Danaher Corporation, BioMerieux, Agilent Technologies, OraSure Technologies Inc., Thermo Fisher Scientific, and Meridian Bioscience Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Point of Care Molecular Diagnostics Market Dynamics
Drivers
Restraints
Opportunity
4. Global Point of Care Molecular Diagnostics Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Point of Care Molecular Diagnostics Market Segmentation, By Application
Global Point of Care Molecular Diagnostics Market Share Analysis, By Application
Global Point of Care Molecular Diagnostics Market Growth Analysis, By Application
Global Point of Care Molecular Diagnostics Market Trends, By Application
o Infectious Diseases
o Oncology
o Hematology
o Prenatal Testing
o Endocrinology
o Other Applications
6. Global Point of Care Molecular Diagnostics Market Segmentation, By Technology
Global Point of Care Molecular Diagnostics Market Share Analysis, By Technology
Global Point of Care Molecular Diagnostics Market Growth Analysis, By Technology
Global Point of Care Molecular Diagnostics Market Trends, By Technology
o PCR
o Genetic Sequencing
o Hybridization
o Microarray
7. Global Point of Care Molecular Diagnostics Market Segmentation, By End User
Global Point of Care Molecular Diagnostics Market Share Analysis, By End User
Global Point of Care Molecular Diagnostics Market Growth Analysis, By End User
Global Point of Care Molecular Diagnostics Market Trends, By End User
o Hospitals
o Homecare
o Other End Users
8. Global Point of Care Molecular Diagnostics Market Segmentation, By Region
Global Point of Care Molecular Diagnostics Market Share Analysis, By Region
Global Point of Care Molecular Diagnostics Market Growth Analysis, By Region
Global Point of Care Molecular Diagnostics Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Abbott Laboratories*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Siemens Healthineers
F. Hoffmann-La Roche Ltd
Becton, Dickinson and Company
Danaher Corporation
BioMerieux
Agilent Technologies
OraSure Technologies Inc.
Thermo Fisher Scientific
Meridian Bioscience Inc.
*Similar analysis will be provided for each company listed above.
